D

Impact BioMedical Inc. IBO

$3.60 -$0.20-5.26% AMEX
Recommendation
Dividend Power Score
Day's Range
$3.54$4.02
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

IBO Rating

Reward
Risk

IBO Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

IBO Company Overview

Impact BioMedical Inc. is a biotechnology and health sciences company focused on developing and commercializing technologies in the areas of biopharmaceuticals, consumer wellness, and specialty health products. The company operates at the intersection of biotechnology research and intellectual property development, with activities centered on identifying, advancing, and licensing proprietary technologies and formulations. Public filings indicate that the company’s strategy emphasizes product innovation, patent development, and strategic commercialization partnerships across healthcare-related markets.

The company’s principal areas of focus have included antiviral and antimicrobial technologies, wellness and nutraceutical products, and platform-based health solutions intended for licensing or commercialization. Impact BioMedical has positioned itself as an intellectual-property-driven enterprise that seeks to monetize patented technologies through development agreements, licensing arrangements, and strategic partnerships. According to public disclosures, the company evolved through acquisitions and development-stage initiatives intended to create a diversified biomedical and wellness portfolio.

Data compiled by narrative technology. May contain errors.
Sector

IBO Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

IBO Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

IBO Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

IBO Price History

Loading...
52-Week Range15% of range
Current
$3.60
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--

IBO Valuation

Market Cap
Market Cap Rank
#13,023
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

IBO Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

IBO Corporate Info

Phone Number
281 415 6576
Address
1400 Broadfield Blvd.
Suite 130
Houston, TX 77084
Country
Year Founded

IBO Filings

Filing Date
Friday, August 7, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)